SeqOne is currently owned by Elaia Partners, through Elaia Delta Fund, since 2019.

When did Elaia Partners acquire SeqOne?

Elaia Partners acquired SeqOne in 2019 (active for 7 years).

Home/Companies/Biotech/SeqOne

SeqOne

Biotech·

France·Active·7yr hold

SeqOne is a software company, headquartered in France.

Entry

2019

Hold

7yr

Status

Active

Est. EV

–

Most recent investor

Elaia Partners

2 ownership periods

Key facts

HQFrance

SectorSoftware

SeqOne is a genetic analysis platform combining AI and big data approaches to make genetic analysis more accessible to doctors treating…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Elaia Delta Fund

6 comparable biotech deals from other GPs

Start free

Already a member? Sign in

Data refreshed weekly · Sourced from public filings